Recon: GSK, Pfizer RSV vaccine sales drop in the US; Sage abandons Alzheimer’s drug after late-stage trial miss
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States